FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:752-758 March 21, 1996 Number 12 Next

Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the 4 Allele for Apolipoprotein E

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Variants of the apolipoprotein E allele appear to account for most cases of late-onset Alzheimer's disease, and persons with two copies of the 4 allele appear to have an especially high risk of dementia. Positron-emission tomography (PET) has identified specific regions of the brain in which the rate of glucose metabolism declines progressively in patients with probable Alzheimer's disease. We used PET to investigate whether these same regions of the brain are affected in subjects homozygous for the 4 allele before the onset of cognitive impairment.

Methods Apolipoprotein E genotypes were established in 235 volunteers 50 to 65 years of age who reported a family history of probable Alzheimer's disease. Neurologic and psychiatric evaluations, a battery of neuropsychological tests, magnetic resonance imaging, and PET were performed in 11 4 homozygotes and 22 controls without the 4 allele who were matched for sex, age, and level of education. An automated method was used to generate an aggregate surface-projection map that compared regional rates of glucose metabolism in the two groups.

Results The 4 homozygotes were cognitively normal. They had significantly reduced rates of glucose metabolism in the same posterior cingulate, parietal, temporal, and prefrontal regions as in previously studied patients with probable Alzheimer's disease. They also had reduced rates of glucose metabolism in additional prefrontal regions, which may be preferentially affected during normal aging.

Conclusions In late middle age, cognitively normal subjects who are homozygous for the 4 allele for apolipoprotein E have reduced glucose metabolism in the same regions of the brain as in patients with probable Alzheimer's disease. These findings provide preclinical evidence that the presence of the 4 allele is a risk factor for Alzheimer's disease. PET may offer a relatively rapid way of testing future treatments to prevent Alzheimer's disease.

Source Information

From the Positron Emission Tomography Center, Good Samaritan Regional Medical Center, Phoenix, Ariz. (E.M.R., L.S.Y., K.C., D.B.); the Departments of Psychiatry (E.M.R.) and Radiology (K.C.), University of Arizona, Tucson; the Departments of Neurology (R.J.C.) and Psychology (D.O.), Mayo Clinic, Scottsdale, Ariz.; the Department of Computer Science, Arizona State University, Tempe (L.S.Y.); the Division of Nuclear Medicine, University of Michigan, Ann Arbor (S.M.); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn. (S.N.T.). Presented in part at the Annual Meeting of the American Academy of Neurology, Seattle, May 12, 1995.

Address reprint requests to Dr. Reiman at the Positron Emission Tomography Center, Good Samaritan Regional Medical Center, 1111 E. McDowell Rd., Phoenix, AZ 85006.

Full Text of this Article

Related Letters:

Positron-Emission Tomography and Alzheimer's Disease
Pedro-Botet J., Rubiés-Prat J., Reiman E. M., Caselli R. J.
Extract | Full Text  
N Engl J Med 1996; 335:207-208, Jul 18, 1996. Correspondence

This article has been cited by other articles:

• Petrie, E. C., Cross, D. J., Galasko, D., Schellenberg, G. D., Raskind, M. A., Peskind, E. R., Minoshima, S. (2009). Preclinical Evidence of Alzheimer Changes: Convergent Cerebrospinal Fluid Biomarker and Fluorodeoxyglucose Positron Emission Tomography Findings. Arch Neurol 66: 632-637 [Abstract] [Full Text]  
• Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., Mackay, C. E. (2009). Distinct patterns of brain activity in young carriers of the APOE-{varepsilon}4 allele. Proc. Natl. Acad. Sci. USA 106: 7209-7214 [Abstract] [Full Text]  
• Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., Alexander, G. E., Klunk, W. E., Mathis, C. A., Price, J. C., Aizenstein, H. J., DeKosky, S. T., Caselli, R. J. (2009). Fibrillar amyloid-{beta} burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 106: 6820-6825 [Abstract] [Full Text]  
• Xu, G., Mclaren, D. G., Ries, M. L., Fitzgerald, M. E., Bendlin, B. B., Rowley, H. A., Sager, M. A., Atwood, C., Asthana, S., Johnson, S. C. (2009). The influence of parental history of Alzheimer's disease and apolipoprotein E {varepsilon}4 on the BOLD signal during recognition memory. Brain 132: 383-391 [Abstract] [Full Text]  
• Chertkow, H., Massoud, F., Nasreddine, Z., Belleville, S., Joanette, Y., Bocti, C., Drolet, V., Kirk, J., Freedman, M., Bergman, H. (2009). Diagnosis and Treatment of Dementia: 3. Mild Cognitive Impairment and Cognitive Impairment Without Dementia. Focus 7: 64-78 [Abstract] [Full Text]  
• Lee, B. K., Glass, T. A., Wand, G. S., McAtee, M. J., Bandeen-Roche, K., Bolla, K. I., Schwartz, B. S. (2008). Apolipoprotein E Genotype, Cortisol, and Cognitive Function in Community-Dwelling Older Adults. Am. J. Psychiatry 165: 1456-1464 [Abstract] [Full Text]  
• Caselli, R. J., Chen, K., Lee, W., Alexander, G. E., Reiman, E. M. (2008). Correlating Cerebral Hypometabolism With Future Memory Decline in Subsequent Converters to Amnestic Pre-Mild Cognitive Impairment. Arch Neurol 65: 1231-1236 [Abstract] [Full Text]  
• Chertkow, H. MD, Massoud, F. MD, Nasreddine, Z. MD, Belleville, S. PhD, Joanette, Y. PhD, Bocti, C. MD, Drolet, V. BSc, Kirk, J. MD, Freedman, M. MD, Bergman, H. MD (2008). Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 178: 1273-1285 [Abstract] [Full Text]  
• Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., Kukull, W., Morris, J. C., Hulette, C. M., Schmechel, D., Rogers, J., Stephan, D. A. (2008). Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. USA 105: 4441-4446 [Abstract] [Full Text]  
• Alexander, G. E., Chen, K., Aschenbrenner, M., Merkley, T. L., Santerre-Lemmon, L. E., Shamy, J. L., Skaggs, W. E., Buonocore, M. H., Rapp, P. R., Barnes, C. A. (2008). Age-Related Regional Network of Magnetic Resonance Imaging Gray Matter in the Rhesus Macaque. J. Neurosci. 28: 2710-2718 [Abstract] [Full Text]  
• Rabinovici, G.D., Seeley, W.W., Kim, E.J., Gorno-Tempini, M.L., Rascovsky, K., Pagliaro, T.A., Allison, S.C., Halabi, C., Kramer, J.H., Johnson, J.K., Weiner, M.W., Forman, M.S., Trojanowski, J.Q., DeArmond, S.J., Miller, B.L., Rosen, H.J. (2008). Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration. AM J ALZHEIMERS DIS OTHER DEMEN 22: 474-488 [Abstract]  
• Petrella, J. R., Mattay, V. S., Doraiswamy, P. M. (2008). Imaging Genetics of Brain Longevity and Mental Wellness: The Next Frontier?. Radiology 246: 20-32 [Abstract] [Full Text]  
• HERHOLZ, K, CARTER, S F, JONES, M (2007). Positron emission tomography imaging in dementia. Br. J. Radiol. 80: S160-S167 [Abstract] [Full Text]  
• Swerdlow, R. H. (2007). PET sheds light on Alzheimer's disease genetic risk. Proc. Natl. Acad. Sci. USA 104: 18881-18882 [Full Text]  
• Johnson, S. C., Ries, M. L., Hess, T. M., Carlsson, C. M., Gleason, C. E., Alexander, A. L., Rowley, H. A., Asthana, S., Sager, M. A. (2007). Effect of Alzheimer Disease Risk on Brain Function During Self-appraisal in Healthy Middle-aged Adults. Arch Gen Psychiatry 64: 1163-1171 [Abstract] [Full Text]  
• Chen, K., Reiman, E. M., Alexander, G. E., Caselli, R. J., Gerkin, R., Bandy, D., Domb, A., Osborne, D., Fox, N., Crum, W. R., Saunders, A. M., Hardy, J. (2007). Correlations Between Apolipoprotein E {epsilon}4 Gene Dose and Whole Brain Atrophy Rates. Am. J. Psychiatry 164: 916-921 [Abstract] [Full Text]  
• Smith, C. D., Chebrolu, H., Wekstein, D. R., Schmitt, F. A., Jicha, G. A., Cooper, G., Markesbery, W. R. (2007). Brain structural alterations before mild cognitive impairment. Neurology 68: 1268-1273 [Abstract] [Full Text]  
• Borroni, B., Di Luca, M., Padovani, A., van der Flier, W .M., Schoonenboom, N .S.M., Pijnenburg, Y .A.L., Fox, N .C., Scheltens, P . (2007). The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 68: 624-624 [Full Text]  
• Parihar, M. S, Brewer, G. J. (2007). Mitoenergetic failure in Alzheimer disease. Am. J. Physiol. Cell Physiol. 292: C8-C23 [Abstract] [Full Text]  
• Wishart, H. A., Saykin, A. J., McAllister, T. W., Rabin, L. A., McDonald, B. C., Flashman, L. A., Roth, R. M., Mamourian, A. C., Tsongalis, G. J., Rhodes, C. H. (2006). Regional brain atrophy in cognitively intact adults with a single APOE {varepsilon}4 allele.. Neurology 67: 1221-1224 [Abstract] [Full Text]  
• Wishart, H. A., Saykin, A. J., Rabin, L. A., Santulli, R. B., Flashman, L. A., Guerin, S. J., Mamourian, A. C., Belloni, D. R., Rhodes, C. H., McAllister, T. W. (2006). Increased Brain Activation During Working Memory in Cognitively Intact Adults With the APOE {epsilon}4 Allele. Am. J. Psychiatry 163: 1603-1610 [Abstract] [Full Text]  
• Small, G. W. (2006). Diagnostic Issues in Dementia: Neuroimaging as a Surrogate Marker of Disease. J Geriatr Psychiatry Neurol 19: 180-185 [Abstract]  
• Kempf, L., Meyer-Lindenberg, A. (2006). Imaging Genetics and Psychiatry. Focus 4: 327- [Abstract] [Full Text]  
• Magistretti, P. J. (2006). Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209: 2304-2311 [Abstract] [Full Text]  
• Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A. (2006). The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.. J. Neurosci. 26: 6069-6076 [Abstract] [Full Text]  
• Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., Zeger, S. L. (2006). Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain 129: 1229-1239 [Abstract] [Full Text]  
• Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Backman, L., Nilsson, L.-G., Petersson, K. M., Nyberg, L. (2006). Reduced functional brain activity response in cognitively intact apolipoprotein E {varepsilon}4 carriers. Brain 129: 1240-1248 [Abstract] [Full Text]  
• Ercoli, L., Siddarth, P., Huang, S.-C., Miller, K., Bookheimer, S. Y., Wright, B. C., Phelps, M. E., Small, G. (2006). Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.. Arch Gen Psychiatry 63: 442-448 [Abstract] [Full Text]  
• Cortelli, P., Perani, D., Montagna, P., Gallassi, R., Tinuper, P., Federica, P., Avoni, P., Ferrillo, F., Anchisi, D., Moresco, R. M., Fazio, F., Parchi, P., Baruzzi, A., Lugaresi, E., Gambetti, P. (2006). Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain 129: 668-675 [Abstract] [Full Text]  
• Bartzokis, G., Lu, P. H., Geschwind, D. H., Edwards, N., Mintz, J., Cummings, J. L. (2006). Apolipoprotein E Genotype and Age-Related Myelin Breakdown in Healthy Individuals: Implications for Cognitive Decline and Dementia. Arch Gen Psychiatry 63: 63-72 [Abstract] [Full Text]  
• Fleisher, A. S., Houston, W. S., Eyler, L. T., Frye, S., Jenkins, C., Thal, L. J., Bondi, M. W. (2005). Identification of Alzheimer Disease Risk by Functional Magnetic Resonance Imaging. Arch Neurol 62: 1881-1888 [Abstract] [Full Text]  
• Velliquette, R. A., O'Connor, T., Vassar, R. (2005). Energy Inhibition Elevates {beta}-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis. J. Neurosci. 25: 10874-10883 [Abstract] [Full Text]  
• Scarmeas, N, Habeck, C G, Hilton, J, Anderson, K E, Flynn, J, Park, A, Stern, Y (2005). APOE related alterations in cerebral activation even at college age. J. Neurol. Neurosurg. Psychiatry 76: 1440-1444 [Abstract] [Full Text]  
• Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., Mintun, M. A. (2005). Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory. J. Neurosci. 25: 7709-7717 [Abstract] [Full Text]  
• Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., Albert, M. S., Sperling, R. A. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65: 404-411 [Abstract] [Full Text]  
• Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., Hardy, J. (2005). From The Cover: Correlations between apolipoprotein E {epsilon}4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. USA 102: 8299-8302 [Abstract] [Full Text]  
• Bunce, D., Kivipelto, M., Wahlin, A. (2005). Apolipoprotein E, B Vitamins, and Cognitive Function in Older Adults. Journals of Gerontology Series B: Psychological Sciences and Social Science 60: P41-P48 [Abstract] [Full Text]  
• Johnson, N. A., Jahng, G.-H., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno-Tempini, M. L., Schuff, N. (2005). Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience. Radiology 234: 851-859 [Abstract] [Full Text]  
• Bondi, M. W., Houston, W. S., Eyler, L. T., Brown, G. G. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64: 501-508 [Abstract] [Full Text]  
• Drzezga, A., Riemenschneider, M., Strassner, B., Grimmer, T., Peller, M., Knoll, A., Wagenpfeil, S., Minoshima, S., Schwaiger, M., Kurz, A. (2005). Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64: 102-107 [Abstract] [Full Text]  
• Caselli, R. J., Reiman, E. M., Hentz, J. G., Osborne, D., Alexander, G. E. (2004). A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes. J. Neuropsychiatry Clin. Neurosi. 16: 320-329 [Abstract] [Full Text]  
• Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., Alexander, G. G. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62: 1990-1995 [Abstract] [Full Text]  
• Tai, Y F, Piccini, P (2004). Applications of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry 75: 669-676 [Abstract] [Full Text]  
• Greicius, M. D., Srivastava, G., Reiss, A. L., Menon, V. (2004). Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc. Natl. Acad. Sci. USA 101: 4637-4642 [Abstract] [Full Text]  
• Mosconi, L, Nacmias, B, Sorbi, S, De Cristofaro, M T R, Fayazz, M, Tedde, A, Bracco, L, Herholz, K, Pupi, A (2004). Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75: 370-376 [Abstract] [Full Text]  
• Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., Hardy, J. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. USA 101: 284-289 [Abstract] [Full Text]  
• Haier, R. J., Alkire, M. T., White, N. S., Uncapher, M. R., Head, E., Lott, I. T., Cotman, C. W. (2003). Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia. Neurology 61: 1673-1679 [Abstract] [Full Text]  
• Greenwood, P. M., Parasuraman, R. (2003). Normal Genetic Variation, Cognition, and Aging. Behav Cogn Neurosci Rev 2: 278-306 [Abstract]  
• Gundel, H., O'Connor, M.-F., Littrell, L., Fort, C., Lane, R. D. (2003). Functional Neuroanatomy of Grief: An fMRI Study. Am. J. Psychiatry 160: 1946-1953 [Abstract] [Full Text]  
• DeKosky, S. T., Marek, K. (2003). Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders. Science 302: 830-834 [Abstract] [Full Text]  
• Scarmeas, N., Habeck, C. G., Stern, Y., Anderson, K. E. (2003). APOE Genotype and Cerebral Blood Flow in Healthy Young Individuals. JAMA 290: 1581-1582 [Full Text]  
• Chetelat, G., Desgranges, B., de la Sayette, V., Viader, F., Berkouk, K., Landeau, B., Lalevee, C., Le Doze, F., Dupuy, B., Hannequin, D., Baron, J.-C., Eustache, F. (2003). Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 126: 1955-1967 [Abstract] [Full Text]  
• Siessmeier, T, Nix, W A, Hardt, J, Schreckenberger, M, Egle, U T, Bartenstein, P (2003). Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 74: 922-928 [Abstract] [Full Text]  
• Kantarci, K., Reynolds, G., Petersen, R. C., Boeve, B. F., Knopman, D. S., Edland, S. D., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Jack, C. R. Jr (2003). Proton MR Spectroscopy in Mild Cognitive Impairment and Alzheimer Disease: Comparison of 1.5 and 3 T. Am. J. Neuroradiol. 24: 843-849 [Abstract] [Full Text]  
• Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., Seeman, T. E. (2003). The role of APOE-{epsilon}4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 60: 1077-1081 [Abstract] [Full Text]  
• Broe, M., Hodges, J.R., Schofield, E., Shepherd, C.E., Kril, J.J., Halliday, G.M. (2003). Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60: 1005-1011 [Abstract] [Full Text]  
• Hariri, A. R, Weinberger, D. R (2003). Imaging genomics. Br Med Bull 65: 259-270 [Abstract] [Full Text]  
• Lee, K. U., Lee, J. S., Kim, K. W., Jhoo, J. H., Lee, D. Y., Yoon, J. C., Lee, J. H., Lee, D. S., Lee, M. C., Woo, J. I. (2003). Influence of the Apolipoprotein E Type 4 Allele on Cerebral Glucose Metabolism in Alzheimer's Disease Patients. J. Neuropsychiatry Clin. Neurosi. 15: 78-83 [Abstract] [Full Text]  
• Selkoe, D. J. (2002). Alzheimer's Disease Is a Synaptic Failure. Science 298: 789-791 [Abstract] [Full Text]  
• Jagust, W. J., Eberling, J. L., Wu, C. C., Finkbeiner, A., Mungas, D., Valk, P. E., Haan, M. N. (2002). Brain function and cognition in a community sample of elderly Latinos. Neurology 59: 378-383 [Abstract] [Full Text]  
• Johnson, S. C., Baxter, L. C., Wilder, L. S., Pipe, J. G., Heiserman, J. E., Prigatano, G. P. (2002). Neural correlates of self-reflection. Brain 125: 1808-1814 [Abstract] [Full Text]  
• Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., Reiman, E. M. (2002). Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am. J. Psychiatry 159: 738-745 [Abstract] [Full Text]  
• Desgranges, B., Baron, J.-C., Lalevee, C., Giffard, B., Viader, F., de la Sayette, V., Eustache, F. (2002). The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain 125: 1116-1124 [Abstract] [Full Text]  
• Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., Avison, M. J. (2002). Women at risk for AD show increased parietal activation during a fluency task. Neurology 58: 1197-1202 [Abstract] [Full Text]  
• Scahill, R. I., Schott, J. M., Stevens, J. M., Rossor, M. N., Fox, N. C. (2002). Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. USA 99: 4703-4707 [Abstract] [Full Text]  
• Hirono, N., Hashimoto, M., Yasuda, M., Ishii, K., Sakamoto, S., Kazui, H., Mori, E. (2002). The effect of APOE {epsilon}4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology 58: 743-750 [Abstract] [Full Text]  
• Silverman, D. H.S., Gambhir, S. S., Huang, H.-W. C., Schwimmer, J., Kim, S., Small, G. W., Chodosh, J., Czernin, J., Phelps, M. E. (2002). Evaluating Early Dementia With and Without Assessment of Regional Cerebral Metabolism by PET: A Comparison of Predicted Costs and Benefits. JNM 43: 253-266 [Abstract] [Full Text]  
• Hargrave, R., Maddock, R. J., Stone, V. (2002). Impaired Recognition of Facial Expressions of Emotion in Alzheimer's Disease. J. Neuropsychiatry Clin. Neurosi. 14: 64-71 [Abstract] [Full Text]  
• Miller, B. L. (2002). Past Glory and Future Promise: Maximizing and Improving Understanding of Atrophy Patterns in the Diagnosis of Degenerative Dementias. Am. J. Neuroradiol. 23: 33-34 [Full Text]  
• Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., Winblad, B. (2001). Current Concepts in Mild Cognitive Impairment. Arch Neurol 58: 1985-1992 [Abstract] [Full Text]  
• Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., Morris, J. C. (2001). Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease. Arch Neurol 58: 1395-1402 [Abstract] [Full Text]  
• de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., Imossi, A., Thorn, E., Bobinski, M., Caraos, C., Lesbre, P., Schlyer, D., Poirier, J., Reisberg, B., Fowler, J. (2001). Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. USA 10.1073/pnas.191044198v1 [Abstract] [Full Text]  
• van Reekum, R., Streiner, D. L., Conn, D. K. (2001). Applying Bradford Hill's Criteria for Causation to Neuropsychiatry: Challenges and Opportunities. J. Neuropsychiatry Clin. Neurosi. 13: 318-325 [Abstract] [Full Text]  
• Valla, J., Berndt, J. D., Gonzalez-Lima, F. (2001). Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration. J. Neurosci. 21: 4923-4930 [Abstract] [Full Text]  
• Ti, L. K., Mathew, J. P., Mackensen, G. B., Grocott, H. P., White, W. D., Reves, J. G., Newman, M. F. (2001). Effect of Apolipoprotein E Genotype on Cerebral Autoregulation During Cardiopulmonary Bypass. Stroke 32: 1514-1519 [Abstract] [Full Text]  
• Johnson, K.A., Lopera, F., Jones, K., Becker, A., Sperling, R., Hilson, J., Londono, J., Siegert, I., Arcos, M., Moreno, S., Madrigal, L., Ossa, J., Pineda, N., Ardila, A., Roselli, M., Albert, M. S., Kosik, K.S., Rios, A. (2001). Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 56: 1545-1551 [Abstract] [Full Text]  
• Ishii, K., Willoch, F., Minoshima, S., Drzezga, A., Ficaro, E. P., Cross, D. J., Kuhl, D. E., Schwaiger, M. (2001). Statistical Brain Mapping of 18F-FDG PET in Alzheimer's Disease: Validation of Anatomic Standardization for Atrophied Brains. JNM 42: 548-557 [Abstract] [Full Text]  
• Kantarci, K., Jack, C. R. Jr, Xu, Y. C., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., Petersen, R. C. (2001). Mild Cognitive Impairment and Alzheimer Disease: Regional Diffusivity of Water. Radiology 219: 101-107 [Abstract] [Full Text]  
• Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., Frost, J. (2001). Declining brain activity in cognitively normal apolipoprotein E varepsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98: 3334-3339 [Abstract] [Full Text]  
• Hogh, P., Knudsen, G. M., Kjaer, K. H., Jorgensen, O. S., Paulson, O. B., Waldemar, G. (2001). Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the {varepsilon}4 Allele on Regional Cerebral Blood Flow. J Geriatr Psychiatry Neurol 14: 42-51 [Abstract]  
• Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., Foster, N. L. (2001). Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss. Arch Neurol 58: 411-416 [Abstract] [Full Text]  
• Bigler, E. D., Lowry, C. M., Anderson, C. V., Johnson, S. C., Terry, J., Steed, M. (2000). Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype. Am. J. Neuroradiol. 21: 1857-1868 [Abstract] [Full Text]  
• Greenwood, P. M., Sunderland, T., Friz, J. L., Parasuraman, R. (2000). Genetics and visual attention: Selective deficits in healthy adult carriers of the varepsilon 4 allele of the apolipoprotein E gene. Proc. Natl. Acad. Sci. USA 97: 11661-11666 [Abstract] [Full Text]  
• Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., Small, G. W. (2000). Patterns of Brain Activation in People at Risk for Alzheimer's Disease. NEJM 343: 450-456 [Abstract] [Full Text]  
• Phelps, M. E. (2000). Inaugural Article: Positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. USA 97: 9226-9233 [Abstract] [Full Text]  
• Kantarci, K., Jack, C. R. Jr., Xu, Y. C., Campeau, N. G., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., Petersen, R. C. (2000). Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55: 210-217 [Abstract] [Full Text]  
• Harwood, D. G., Barker, W. W., Ownby, R. L., Mullan, M. J., Duara, R. (2000). Family History of Dementia and Current Depression in Nondemented Community-Dwelling Older Adults. J Geriatr Psychiatry Neurol 13: 65-71 [Abstract]  
• Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., D'Agostino, R. B. (2000). The Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort. Arch Neurol 57: 808-813 [Abstract] [Full Text]  
• Dik, M. G., Jonker, C., Bouter, L. M., Geerlings, M. I., van Kamp, G. J., Deeg, D. J. H. (2000). APOE-{epsilon}4 is associated with memory decline in cognitively impaired elderly. Neurology 54: 1492-1497 [Abstract] [Full Text]  
• Riley, K. P., Snowdon, D. A., Saunders, A. M., Roses, A. D., Mortimer, J. A., Nanayakkara, N. (2000). Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study. Journals of Gerontology Series B: Psychological Sciences and Social Science 55: 69S-75 [Abstract] [Full Text]  
• Green, J., Levey, A. I. (1999). Event-Related Potential Changes in Groups at Increased Risk for Alzheimer Disease. Arch Neurol 56: 1398-1403 [Abstract] [Full Text]  
• Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., Avison, M. J. (1999). Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53: 1391-1391 [Abstract] [Full Text]  
• Jack, C. R. Jr., Petersen, R. C., Xu, Y. C., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., Kokmen, E. (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52: 1397-1397 [Abstract] [Full Text]  
• Reed, B. R., Jagust, W. J. (1999). Opening a window on cerebral cholinergic function. Neurology 52: 680-680 [Full Text]  
• Hardy, J., Gwinn-Hardy, K. (1998). Genetic Classification of Primary Neurodegenerative Disease. Science 282: 1075-1079 [Abstract] [Full Text]  
• van Dyck, C. H., Gelernter, J., MacAvoy, M. G., Avery, R. A., Criden, M., Okereke, O., Varma, P., Seibyl, J. P., Hoffer, P. B. (1998). Absence of an Apolipoprotein E {epsilon}4 Allele Is Associated With Increased Parietal Regional Cerebral Blood Flow Asymmetry in Alzheimer Disease. Arch Neurol 55: 1460-1466 [Abstract] [Full Text]  
• Growdon, J. H. (1998). Apolipoprotein E and Alzheimer Disease. Arch Neurol 55: 1053-1054 [Full Text]  
• Yasuda, M., Mori, E., Kitagaki, H., Yamashita, H., Hirono, N., Shimada, K., Maeda, K., Tanaka, C. (1998). Apolipoprotein E {epsilon}4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease. Am. J. Psychiatry 155: 779-784 [Abstract] [Full Text]  
• Lehtovirta, M, Kuikka, J, Helisalmi, S, Hartikainen, P, Mannermaa, A, Ryynanen, M, Riekkinen, P S., Soininen, H (1998). Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J. Neurol. Neurosurg. Psychiatry 64: 742-746 [Abstract] [Full Text]